This is the result of government protectionism and cronyism. The CEO of Mylan is the daughter of a Democrat senator. Not surprisngly, the FDA has protected Mylan from competitors that would prevent this type of price gouging by making it more difficult for would-be competitors to create a similar injection device. Potential competitors have been working on this, and have been directly blocked by the FDA.
Greed. I get she is doing what is best for her stockholders, but there is a social and human cost here. I hope investors walk away and competitors rise to put this company out of business. It would make it a lesson for others. There should be a price for greed at the expense of others.